Trial Profile

E3810-A001-312: Efficacy and Safety of 10 Mg Rabeprazole for Treating Heartburn in Frequent Sufferers

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 14 Nov 2009

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rabeprazole (Primary)
Indications Heartburn
Focus Therapeutic Use

Most Recent Events

25 Feb 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov, last updated 25-Feb-2009.
25 Feb 2009 Actual patient number (619) added as reported by ClinicalTrials.gov.
24 Jun 2008 Actual end date for this trial is now Jun 2008 as reported by ClinicalTrials.gov

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com